0 CHECKOUT

Gilead Sciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • ID: 2824553
  • June 2016
  • 250 pages
  • MarketLine
1 of 3

Summary
Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

This report includes Gilead Sciences, Inc.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Gilead Sciences, Inc.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Key Findings
Gilead Sciences, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), READ MORE >

Note: Product cover images may vary from those shown
2 of 3

COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
Mergers and Acquisitions – Overview
Mergers and Acquisitions – Deal reports
CORPORATE VENTURING
Corporate Venturing – Overview
Corporate Venturing – Deal reports
PARTNERSHIP
Partnership – Overview
Partnership – Deal reports
CAPITAL RAISING
Capital Raising – Overview
Capital Raising – Deal reports
Private Equity and Ownership – Deal reports

APPENDIX
About the Author Financial Deals Database
Deal Definition and Methodology
About the Author

List of Tables

Gilead Sciences activity by deal type – volume (trailing twelve months (TTM))
Gilead Sciences M&A activity by geography (TTM)
Gilead Sciences activity by deal type – volume (2012 -YTD2016)
Gilead Sciences M&A average deal size – value ($m) (2012 -YTD2016)
Gilead Sciences legal advisor ranking by value ($m)
Gilead Sciences financial advisor ranking by value ($m)
Top Deals(2012 -YTD2016)
Gilead Sciences targets and partners (2012 -YTD2016)
Gilead Sciences M&A volume and value trend (2012-YTD2016)
Gilead Sciences M&A activity by geography (2012-YTD2016)
Gilead Sciences corporate venturing volume and value trend (2012-YTD2016)
Gilead Sciences corporate venturing by geography (2012-YTD2016)
Gilead Sciences partnership volume and value trend (2012-YTD2016)
Gilead Sciences partnership trend by key deal type (2012-YTD2016)
Gilead Sciences capital raising volume and value trend (2012-YTD2016)
Gilead Sciences capital raising by deal type (2012-YTD2016)

List of Figures

Gilead Sciences activity by deal type - volume (trailing twelve months (TTM))
Gilead Sciences M&A activity by geography (TTM)
Gilead Sciences activity by deal type - volume (2012-YTD2016)
Gilead Sciences M&A average deal size - value ($m)
Gilead Sciences M&A volume and value trend (2012-YTD2016)
Gilead Sciences M&A activity by geography (2012-YTD2016)
Gilead Sciences corporate venturing volume and value trend (2012-YTD2016)
Gilead Sciences corporate venturing by geography (2012-YTD2016)
Gilead Sciences partnership volume and value trend (2012-YTD2016)
Gilead Sciences partnership trend by key deal type (2012-YTD2016)
Gilead Sciences capital raising volume and value trend (2012-YTD2016)
Gilead Sciences capital raising by deal type (2012-YTD2016)

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.